|
|
|
Volumn 12, Issue 2, 2007, Pages
|
|
Phase III anti-HIV microbicide trial in Africa and India stopped as preliminary results show gel may increase risk of infection.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CELLULOSE;
CELLULOSE SULFATE;
DRUG DERIVATIVE;
TOPICAL ANTIINFECTIVE AGENT;
AFRICA;
FEMALE;
GEL;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INDIA;
METHODOLOGY;
PHASE 3 CLINICAL TRIAL;
REVIEW;
RISK FACTOR;
AFRICA;
ANTI-HIV AGENTS;
ANTI-INFECTIVE AGENTS, LOCAL;
CELLULOSE;
CLINICAL TRIALS, PHASE III;
FEMALE;
GELS;
HIV INFECTIONS;
HUMANS;
INDIA;
RISK FACTORS;
|
|
EID: 34047247512
PISSN: None
EISSN: 15607917
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (6)
|